About Avedian
Avedian is a company based in Cordoba (Argentina) founded in 2006. It operates as a B2B and SaaS. Avedian has raised $2.2 million across 1 funding round from investors including Meet Capital. Avedian offers products and services including GRD Agrupador, Analítica Avanzada, and Acuerdo de Riesgo Compartido. Avedian operates in a competitive market with competitors including MD Insider, Stellation Care, Altheia, Data Activators and ValueSCORE, among others.
- Headquarter Cordoba, Argentina
-
Sectors
Technology
-
Phone
Locked
-
Website
Locked
-
Social
Locked
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Total Equity Funding
$2.2 M (USD)
in 1 rounds
-
Latest Funding Round
$2.2 M (USD), Seed
Dec 09, 2025
- Investors
-
Employee Count
Not available
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Avedian
Avedian offers a comprehensive portfolio of products and services, including GRD Agrupador, Analítica Avanzada, and Acuerdo de Riesgo Compartido.
Standardizes healthcare casuistry for efficient hospital management.
Delivers predictive insights for clinical and economic decisions.
Facilitates access to innovative medications via aligned interests.
Funding Insights of Avedian
Avedian has successfully raised a total of $2.2M through 1 strategic funding round. The most recent funding activity was a Seed round of $2.2 million completed in December 2025. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in Avedian
Avedian has secured backing from 1 investor, including venture fund investors. Prominent investors backing the company include Meet Capital.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
-
|
Locked | Locked | Locked |
Investor details for Avedian
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Avedian
Investment portfolio details for Avedian
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Avedian
Detailed financials for Avedian
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Avedian Comparisons
Peer comparison for Avedian
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Avedian
Avedian operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as MD Insider, Stellation Care, Altheia, Data Activators and ValueSCORE, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Physician quality scores are derived from mined health data.
|
|
| Locked | Locked | Locked |
A platform for doctor listings and patient consultations is provided.
|
|
| Locked | Locked | Locked |
An AI-powered predictive analytics platform for the healthcare industry.
|
|
| Locked | Locked | Locked |
Delivers comprehensive healthcare analytics solutions for organizations.
|
|
| Locked | Locked | Locked |
Tool that assesses healthcare organizations' safety, cost, outcomes, risk, and engagement metrics.
|
Detailed competitors of Avedian
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Avedian
Complete news archive for Avedian
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Avedian
Avedian was founded in 2006 and raised its 1st funding round 19 years after it was founded.
Avedian is headquartered in Cordoba, Argentina. It is registered at Cordoba, Cordoba, Argentina.
Avedian is a funded company, having raised a total of $2.2M across 1 funding round to date.
Avedian integrates clinical and economic data using AI to deliver strategic insights for healthcare organizations. It offers tools like GRD agrupators and risk-sharing agreements to optimize resources and improve outcomes. Based in Latin America, it serves hospitals, insurers, and pharmaceutical labs through advanced analytics and predictive models for efficient decision-making.
Avedian's top competitors include MD Insider, Stellation Care and Altheia.
Avedian offers GRD Agrupador, Analítica Avanzada, and Acuerdo de Riesgo Compartido.
Avedian has 1 investor. Key investors include Meet Capital.